琥珀酸脱氢酶缺陷型肾细胞癌的临床试验
总计1920个结果
-
ExelixisArcus Biosciences, Inc.招聘中
-
Duke UniversityNovartis; Pfizer完全的
-
Telix International Pty LtdGrand Pharmaceutical (China) Co., Ltd.完全的
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)主动,不招人
-
PfizerAnalysis Group; IMDC group完全的
-
Pfizer完全的转移性肾细胞癌 (mRCC)西班牙, 意大利, 比利时, 法国, 英国, 奥地利, 希腊, 荷兰
-
Bristol-Myers SquibbOno Pharmaceutical Co. Ltd主动,不招人
-
University Hospital, Bordeaux完全的
-
RenJi HospitalThe First Affiliated Hospital with Nanjing Medical University; Peking University First Hospital 和其他合作者招聘中
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...Ministero della Salute, Italy招聘中
-
PfizerInternational Metastatic Renal Cell Carcinoma Database Consortium (IMDC); Analysis Group完全的
-
Ludwig Institute for Cancer ResearchPfizer; Heidelberg Pharma AG终止
-
UNICANCERBristol-Myers Squibb完全的
-
Assistance Publique - Hôpitaux de ParisPfizer完全的
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...完全的
-
NewLink Genetics Corporation完全的
-
Spanish Oncology Genito-Urinary Group完全的
-
Immatics Biotechnologies GmbH完全的
-
Peking University Cancer Hospital & Institute未知
-
Imperial College Healthcare NHS Trust撤销
-
City of Hope Medical CenterNational Cancer Institute (NCI)撤销转移性肾细胞癌 | IV 期肾细胞癌 AJCC v8
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)终止
-
Memorial Sloan Kettering Cancer Center主动,不招人
-
National Cancer Institute (NCI)完全的复发性子宫体肉瘤 | 复发性肾细胞癌 | III期肾细胞癌 | 肺类癌 | IV 期肾细胞癌 | 复发性消化系统神经内分泌肿瘤G1 | 成人实体瘤 | IIIB期子宫肉瘤 | IIIC期子宫肉瘤 | IVA期子宫肉瘤 | IVB期子宫肉瘤加拿大
-
All India Institute of Medical Sciences, New Delhi完全的